Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Edding Genor Group HoldingsHKSE:06998 +0.33%15 Interest Coverage is 3.89 as of Dec. 2025, which is 20% above its 10-year median of 3.23. GuruFocus rates HKSE:06998 with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 685 Drug Manufacturers companies, Edding Genor Group Holdings ranks worse than 75.91% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Edding Genor Group Holdings's
Operating Income
for the
six
months ended in Dec. 2025 was HK$709 Mil. Edding Genor Group Holdings's Interest Expense for the
six
months ended in Dec. 2025 was HK$-182 Mil.
Edding Genor Group Holdings's interest coverage for the quarter that ended in Dec. 2025 was 3.89.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Edding Genor Group Holdings's Interest Coverage or its related term are showing as below:
HKSE:06998'
s Interest Coverage Range Over the Past 10 Years
Min: 2.56 Med: 3.23 Max: 3.89
Current: 3.89
HKSE:06998's Interest Coverage is ranked worse than 75.91% of 685
companies
in the Drug Manufacturers industry
Industry Median: 13.55
vs HKSE:06998: 3.89
Edding Genor Group Holdings (HKSE:06998) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Edding Genor Group Holdings Interest Coverage Related Terms
Edding Genor Group Holdings Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Edding Genor Group Holdings Interest Coverage Chart
Edding Genor Group Holdings Annual Data
Trend
Dec24
Dec25
Interest Coverage
2.56
3.89
Edding Genor Group Holdings Semi-Annual Data
Dec24
Dec25
Interest Coverage
2.56
3.89
HKSE:06998 vs ZTS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Edding Genor Group Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edding Genor Group Holdings Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Edding Genor Group Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Edding Genor Group Holdings's Interest Coverage falls into.
Edding Genor Group Holdings Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edding Genor Group Holdings (HKSE:06998) has a Interest Coverage of 3.89 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Edding Genor Group Holdings and its competitors. This is 20% above median its historical median of 3.23. Over the past decade, Edding Genor Group Holdings' Interest Coverage has ranged from 2.56 to 3.89. According to the industry distribution chart, Edding Genor Group Holdings ranks #520 out of 685 companies in the Drug Manufacturers industry, placing it in the top 75.9%.
Is Edding Genor Group Holdings' Interest Coverage too high?
Edding Genor Group Holdings' current Interest Coverage of 3.89 is 20% above median its 10-year median of 3.23. Over the past 10 years, this metric has ranged from a low of 2.56 to a high of 3.89. The Drug Manufacturers industry median Interest Coverage is 13.55. Edding Genor Group Holdings' value of 3.89 is 71.3% below this industry median. Based on the distribution chart, Edding Genor Group Holdings ranks #520 out of 685 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Edding Genor Group Holdings has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Edding Genor Group Holdings' Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Edding Genor Group Holdings ranks #520 out of 685 companies for Interest Coverage. This places Edding Genor Group Holdings in the lower half of its industry. The industry median Interest Coverage is 13.55. Edding Genor Group Holdings' value of 3.89 is 71.3% below this benchmark. Historically, Edding Genor Group Holdings' own Interest Coverage has ranged from 2.56 to 3.89 over the past decade. While the company's 10-year median is 3.23 vs. the industry median of 13.55, Edding Genor Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 13.55, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edding Genor Group Holdings's current Interest Coverage of 3.89 is 71.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Edding Genor Group Holdings and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 13.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edding Genor Group Holdings's current Interest Coverage is 3.89, which is 20% above median its own 10-year median of 3.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edding Genor Group Holdings stock overvalued right now?
Edding Genor Group Holdings (HKSE:06998) has a current Interest Coverage of 3.89. The current Interest Coverage is 3.89, which is 20% above median its 10-year median of 3.23 and 71.3% below the Drug Manufacturers industry median of 13.55. Edding Genor Group Holdings' overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Edding Genor Group Holdings (HKSE:06998), the current Interest Coverage is 3.89 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.
15GF Score
Get the complete analysis for HKSE:06998
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06998 has been successfully added to your 
